Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Deadline
30.06.2026
Published
26.10.2026
Awarded
26.10.2026
Preliminary Market Engagement for Real Time Location System (
Open for bids·Oct 19
Purchase of lightsouce
Awarded·Oct 16
Purchase of Cardiotocography machines
Awarded·Oct 12
Purchase of ENT Microscopes
Awarded·Oct 7
Rental of 1 x Interventional Radiology Suite
Awarded·Oct 6
Linen & Laundry - Managed Services
Awarded·Sep 29
Histology Reporting
Awarded·Oct 14
WSFT - Pathology - Bloodtrack software support
Awarded·Oct 9
WSFT - Pathology - AlinIQ Indexor
Awarded·Oct 9
WSFT - Pathology - Bloodtrack software support
Awarded·Oct 1
WSFT - Managed Service - Pathology - Microbiology testing Pro-Lab Diagnostics
Awarded·Sep 4
Pathology Managed Service for Midlands & East 2 Network
Awarded·Jul 10
The Responsible Medical Officer (RMO) Braintree
Awarded·Oct 26
The Purchase of 8 seater Vehicles
Awarded·Oct 26
CPU 8676 Planting of meadow turf in three areas and 2 years of Establishment at St Peter's Street
Awarded·Oct 26
26064 Cambridgeshire Carriageway Resurfacing 26/27 - Package 1 (Further Competition EHF 4, Lot 1)
Awarded·Oct 26
37418 - West Gate School
Awarded·Oct 26
Digital and Technology Solutions Apprenticeship Level 6
Awarded·Oct 26
Create an account to explore this tender and find similar opportunities.